Back

Hyperglycaemia-induced trained immunity alters monocyte function in type 2 diabetes patients after myocardial infarction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology in acute coronary syndromes (1) Inflammation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Tafadzwa Taurai Jeffry Kufazvinei

Oxford (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
SMC-derived foam cells regulate atherosclerotic plaque stability via the crosstalk between ECM remodeling and WNT signaling
Mx C. Li (Qingdao, CN)
Abstract Slides Video
Presentation thumbnail
Exploring the role of galectin-3 and pentraxin-3 as biomarkers in chronic coronary syndrome with atrial fibrillation: insights from an 87-patient cohort
Doctor A. Oancea (Iasi, RO)
Abstract Slides Video
Presentation thumbnail
High apo-CIII level correlates with poor lipid status, pro-inflammatory and fibrotic biomarker profile, and adverse cardiovascular outcome in patients with recent acute coronary syndrome
Ms S. Nilsson (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Gut microbiota-derived imidazole propionate is a novel marker of cardiometabolic risk in patients with coronary artery disease
Doctor F. Wenzl (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Cigarette smoking and release of the inflammatory chemokine CXCL10 (IP-10) after ST-elevation myocardial infarction
Doctor L. Spray (Newcastle-Upon-Tyne, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiology in acute coronary syndromes (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Metabolic reprogramming and crosstalk in cardiometabolic and vascular disease
thumbnail
Congress Session
Inflammation in heart failure
thumbnail
Congress Presentation
Anti-inflammatory protection of early vs delayed sodium-glucose cotransporter-2 inhibitor therapy on monocyte-derived macrophages from patients with type2 diabetes with acute myocardial infarction.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources